Cardiovascular Effects of COVID

Order byBest matchMost fresh

COVID, FDA and Heart Risk

FDA expands COVID vaccine warning about heart side effect risk for young males

"Following administration of the 2023-2024 Formula of mRNA COVID-19 vaccines, the highest estimated incidence of myocarditis and/or pericarditis was in males 16 through 25 years of age," the FDA says...

· 2d · on MSN

· 1d

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

· 2d · on MSN

US officials delayed warning public about heart inflammation risk from COVID shot: report

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

MIT Technology Review · 23h

· 5h

Uncertainty loomed as FDA advisors met to discuss this year’s COVID shot

Arizona PBS · 15h

FDA ends routine COVID shots for healthy young Americans

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

· 17h

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

· 1d

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

Medscape11d

Cardiovascular Implications of Long COVID, Severe COVID: What to Know, How to Manage

Cardiovascular issues are common, and now some experts term severe COVID an independent coronary artery disease risk factor needing aggressive management.

The American Journal of Managed Care18h

CBD-Based Drug Shows No Heart Safety Risks in Patients With CVD or Risk Factors

A pharmaceutical-grade cannabidiol (CBD) product was shown to be safe in high-risk patients hospitalized with COVID-19, with no increased rate of cardiac side effects compared with placebo.

1don MSN

GOP Senate report finds Biden health officials misled public about risks of myocarditis from COVID-19 vaccines

The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.